Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, Spain, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.
Metrics to compare | BLUJ | Peers Peers - average of corresponding metrics from companies closely matching BLUJ: MOREPENLAB, KOPRAN, 540694, 524790, CIPLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLUJPeersSector |
---|---|---|---|---|
P/E Ratio | 56.2x | 16.5x | −0.5x | |
PEG Ratio | 1.63 | 0.26 | 0.00 | |
Price/Book | 14.3x | 3.3x | 2.6x | |
Price / LTM Sales | 15.1x | 2.6x | 2.9x | |
Upside (Analyst Target) | 1.2% | 17.8% | 58.9% | |
Fair Value Upside | Unlock | 6.8% | 8.0% | Unlock |